Abstract:Lipid nanoparticle (LNP) formulation was the first approved delivery strategy for liver-targeted siRNA delivery and currently represent the most advanced platform for delivery of therapeutic mRNA in clinical use, after the approval of mRNA-based vaccines against the SARS-CoV-2 coronavirus. Still, poor efficiency of LNPs to promote cytosolic delivery of both mRNA and siRNA after internalization by target cells limits their potency and thus clinical application as RNA delivery vehicles - especially in extrahepatic tissues and tumors. It is still unclear how endosomal escape of LNP-delivered RNA cargo occurs, and why only a minute proportion of all therapeutic molecules reach the cytoplasm. Here, we explored the intracellular sorting, integrity and endosomal escape of both mRNA and siRNA loaded LNPs to characterize the nature of RNA release from endosomal compartments and pinpoint current bottlenecks. Using live-cell imaging and super-resolution microscopy of LNPs with fluorescently labeled RNA payload, we identify multiple distinct steps of substantial inefficiency in the cytosolic delivery of nucleic acid cargoes. We demonstrate that membrane damages marked by recruitment of galectins are conducive to cytosolic RNA delivery, while membrane perturbations recruiting the ESCRT machinery do not permit endosomal escape. By quantitative single-vesicle analysis, we show that only a small fraction of the nucleic acid cargo contained in the endosome is released to the cytosol upon LNP-triggered membrane damage detected by galectins. Unexpectedly, we also observe that only a subset of damaged endosomes contain RNA payload. Through FRET and super-resolution microscopy, using LNPs formulated with both fluorescently labeled ionizable lipid (MC3-BODIPY) and RNA, we find that RNA cargo and ionizable lipid segregate during endosomal sorting - both within single endosomes and to different endosomal compartments. Finally, we visualize localized MC3-BODIPY enrichment in endosomal membranes and membrane damage in direct proximity to siRNA-LNPs tethered to the luminal vesicle membrane. Taken together, this work has identified multiple mechanistically distinct barriers limiting intracellular RNA delivery by LNPs.

Ionizable nanoemulsions for RNA delivery into the central nervous system - importance of diffusivity

Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles

Tetrahydropyrimidine Ionizable Lipids for Efficient mRNA Delivery

Intranasal Delivery and Transfection of mRNA Therapeutics in the Brain Using Cationic Liposomes.

Ddel-01. Engineering Mrna Therapies For Brain Tumors

Ionizable Lipid Nanoparticles for Therapeutic Base Editing of Congenital Brain Disease

The engineering challenges and opportunities when designing potent ionizable materials for the delivery of ribonucleic acids

Untying a Nanoscale Knotted Polymer Structure to Linear Chains for Efficient Gene Delivery in Vitro and to the Brain

Direct cytoplasmic delivery of RNAi therapeutics through a non-lysosomal pathway for enhanced gene therapy

Lipid Nanoparticles Deliver mRNA to the Brain after an Intracerebral Injection

Ionic liquid-coated lipid nanoparticles increase siRNA uptake into CNS targets

Evaluating how cationic lipid affects mRNA-LNP physical properties and biodistribution

Branched‐Tail Lipid Nanoparticles for Intravenous mRNA Delivery to Lung Immune, Endothelial, and Alveolar Cells in Mice

Multicomponent Lipid Nanoparticles for RNA Transfection

Next-generation materials for RNA-lipid nanoparticles: Lyophilization and targeted transfection

Enhancing RNA-lipid nanoparticle delivery: Organ- and cell-specificity and barcoding strategies

Cellular and biophysical barriers to lipid nanoparticle mediated delivery of RNA to the cytosol

Nanoparticle-mediated delivery of oligonucleotides to the blood–brain barrier: in vitro and in situ brain perfusion studies on the uptake mechanisms

Barriers to Non-Viral Vector-Mediated Gene Delivery in the Nervous System

Engineered chitosan-derived nanocarrier for efficient siRNA delivery to peripheral and central neurons

Nucleic Acid Delivery by Solid Lipid Nanoparticles Containing Switchable Lipids: Plasmid DNA vs. Messenger RNA